Beth Israel Deaconess Medical Center
Urology residency · Boston, MA · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Beth Israel Deaconess Medical Center's research in urology, which the program shares with other departments and affiliated hospitals.
About Beth Israel Deaconess Medical Centerinstitution-wide urology research
Urology publications from Beth Israel Deaconess Medical Center and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
34
works per year
12th of 62 urology residency programs
-16.4%
2-year growth
48th of 61 urology residency programs
15.4%
in top 10% of field (works before 2025)
35th of 44 urology residency programs
43.3%
cited above world average
35th of 44 urology residency programs
Works per year · * 2026 so far
Urology · 164
Urology research topics at Beth Israel Deaconess Medical Center
Papers in the window; each links to the list on OpenAlex.
- Prostate Cancer Diagnosis and Treatment 57
- Urinary Bladder and Prostate Research 46
- Pelvic floor disorders treatments 22
- Urinary Tract Infections Management 15
- Kidney Stones and Urolithiasis Treatments 7
- Ureteral procedures and complications 6
- Urological Disorders and Treatments 5
- Male Reproductive Health Studies 4
Most cited at Beth Israel Deaconess Medical Center since 2024
All urology papers there on OpenAlex
- Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate CancerLisa F. Newcomb et al. · JAMA · 2024 · PubMed · cited 80
- Summary of the 2024 Update of the European Association of Urology Guidelines on Neuro-urologyAndrea M. Sartori et al. · European Urology · 2024 · PubMed · cited 71
- Current state and novel outlook on prevention and treatment of rising antibiotic resistance in urinary tract infectionsEmina Karahmet Sher et al. · Pharmacology & Therapeutics · 2024 · PubMed · cited 55
- Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trialRana R. McKay et al. · Cancer · 2024 · PubMed · cited 16
- Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate CancerPraful Kumar Ravi et al. · European Urology · 2025 · PubMed · cited 15
- Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2Christina Sharkey et al. · The Journal of Pathology · 2024 · PubMed · cited 10
- Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate CancerRoman Gulati et al. · Annals of Internal Medicine · 2024 · PubMed · cited 9
- SRD5A2 and emerging therapies in androgen-driven disordersZongwei Wang et al. · Nature Reviews Urology · 2026 · PubMed · cited 8
- Adiponectin signaling regulates urinary bladder function by blunting smooth muscle purinergic contractilityZhao‐Bo Luo et al. · JCI Insight · 2025 · PubMed · cited 8
- National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design ConsiderationsDavid Johnson Einstein et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 7